Back

Chronic kidney disease and third generation antiplatelet therapy among real-word acute coronary syndrome patients: Impact on the prognosis at 1-year of the ACHILLES Registry

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Pharmacologic treatment of acute coronary syndromes Pharmacotherapy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Antonio Tello Montoliu

Virgen de la Arrixaca University Clinical Hospital, El Palmar (Spain)

6 More presentations in this session

Presentation thumbnail
Comparison of clopidogrel with ticagrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention: interim analysis of COSTIC study
Doctor Y. Sun (Wuhan, CN)
Abstract
Presentation thumbnail
Laboratory monitoring of efficacy and safety of atorvastatin high doses in myocardial infarction with ST-segment elevation
Associate Professor L. Salyamova (Penza, RU)
Abstract Slides
Presentation thumbnail
Loading dual antiplatelet therapy in Chinese STEMI patients: results from China STEMI Care Project phase 1 (CSCAP-1)
Doctor Y. Zhang (Beijing, CN)
Abstract
Presentation thumbnail
Efficiency of quercetin in complex treatment of acute myocardial infarction with ST segment elevation
Doctor M. Mirmaksudov (Tashkent, UZ)
Abstract Slides
Presentation thumbnail
Nephroprotective effect of lipid-lowering therapy in patients after STEMI
Professor V. Oleinikov (Penza, RU)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 5 - Pharmacologic treatment of acute coronary syndromes

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources